It has been reported that TFPI-2 diminishes plasmin- and trypsin-mediated activation of pro-MMP-1 and pro-MMP-3, leading to decreased ECM degradation and invasion of HT-1080 fibrosarcoma cells [72]. Here, TFPI2 is linked to fibrosarcoma.